esketamine has been researched along with Chemical Dependence in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 4 (80.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andriola, I; Barlati, S; Bassetti, R; Chiappini, S; Clerici, M; d'Andrea, G; De Filippis, S; Dell'Osso, B; Di Nicola, M; Martinotti, G; Pettorruso, M; Sensi, S; Vita, A | 1 |
| De Fazio, P; de Filippis, R | 1 |
| Borissova, A; Curran, HV; Grabski, M; Marsh, B; Morgan, CJA | 1 |
| Berk, M; Brietzke, E; Dodd, S; Gorwood, P; Ho, R; Iosifescu, DV; Kasper, S; Kratiuk, K; Lee, JG; Lee, Y; Lopez Jaramillo, C; Lui, LMW; Mansur, RB; McIntyre, RS; Murrough, JW; Nemeroff, CB; Papakostas, GI; Rosenblat, JD; Sanacora, G; Stahl, S; Subramaniapillai, M; Thase, M; Vieta, E; Young, AH; Zarate, CA | 1 |
| Fonseca-Perezamador, A; García-Mendoza, AM; Kobayashi-Romero, LF; Lamas-Aguilar, RM; Pérez-Esparza, R | 1 |
2 review(s) available for esketamine and Chemical Dependence
| Article | Year |
|---|---|
Ketamine as a mental health treatment: Are acute psychoactive effects associated with outcomes? A systematic review.
Topics: Adult; Antidepressive Agents; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Female; Humans; Ketamine; Male; Mental Disorders; Mental Health; Middle Aged; Psychotropic Drugs; Substance-Related Disorders; Treatment Outcome | 2020 |
Synthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and Implementation.
Topics: Antidepressive Agents; Delivery of Health Care; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Dissociative Disorders; Excitatory Amino Acid Antagonists; Humans; Hypertension; Implementation Science; Ketamine; Lower Urinary Tract Symptoms; Monitoring, Physiologic; Patient Selection; Personnel Staffing and Scheduling; Psychoses, Substance-Induced; Substance-Related Disorders; Suicidal Ideation | 2021 |
3 other study(ies) available for esketamine and Chemical Dependence
| Article | Year |
|---|---|
Esketamine in treatment-resistant depression patients comorbid with substance-use disorder: A viewpoint on its safety and effectiveness in a subsample of patients from the REAL-ESK study.
Topics: Administration, Intranasal; Adult; Antidepressive Agents; Comorbidity; Depression; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Drug-Related Side Effects and Adverse Reactions; Humans; Ketamine; Retrospective Studies; Substance-Related Disorders | 2023 |
Esketamine nasal spray in severe bipolar depression with borderline personality disorder and history of multiple substance abuse: A case report.
Topics: Bipolar Disorder; Borderline Personality Disorder; Humans; Nasal Sprays; Substance-Related Disorders | 2023 |
Promises and concerns regarding the use of ketamine and esketamine in the treatment of depression.
Topics: Administration, Intranasal; Anesthetics, Dissociative; Antidepressive Agents; Brain-Derived Neurotrophic Factor; Depressive Disorder, Treatment-Resistant; Humans; Ketamine; Receptors, N-Methyl-D-Aspartate; Risk Factors; Substance-Related Disorders; Suicidal Ideation; United States; United States Food and Drug Administration | 2019 |